Daniel specialises in advising and representing national and international clients in the life sciences sector. His focus is, among others, on all areas of pharmaceutical law, medical device law, pharmaceutical-advertising law, unfair competition law, and trademark law.

 

For more than 10 years, he has been coordinating and supervising disputes concerning competition law and trademark law for his clients and has, besides his specific focus on litigation, also longstanding experience in advising clients on regulatory and compliance matters, particularly, in the aforementioned areas of law. In context with managing litigation and advising his clients, Daniel is characterised by a strong client focus and his ability to find appropriate and efficient solutions to legal problems.

显示完整简历 隐藏完整简历

最新新闻和观点

专利与创新

Federal Government White Paper on the Legalisation of Cannabis Products - Details and Questions under European Law

2022年11月8日
Briefing

作者 Dr. Daniel Tietjen

点击此处了解更多
酒店与休闲

TAMG – the new Veterinary Medicinal Products Act

2022年9月14日
Briefing

作者 Dr. Daniel Tietjen

点击此处了解更多
产品责任与产品安全

Judgement of the Administrative Court of Cologne: Classification of CBD drops as medicinal products subject to authorization

2022年9月14日
Briefing

作者 Dr. Daniel Tietjen

点击此处了解更多
产品责任与产品安全

Standstill in the approval process for CBD products as novel foods

2022年9月14日
Briefing

作者 Dr. Daniel Tietjen

点击此处了解更多

与我会面: